Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.

Huber AD, Wolf JJ, Liu D, Gres AT, Tang J, Boschert KN, Puray-Chavez MN, Pineda DL, Laughlin TG, Coonrod EM, Yang Q, Ji J, Kirby KA, Wang Z, Sarafianos SG.

mSphere. 2018 Apr 18;3(2). pii: e00131-18. doi: 10.1128/mSphereDirect.00131-18. Print 2018 Apr 25.

2.

Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.

Xia C, Wolf JJ, Vijayan M, Studstill CJ, Ma W, Hahm B.

J Virol. 2018 Mar 14;92(7). pii: e00006-18. doi: 10.1128/JVI.00006-18. Print 2018 Apr 1.

PMID:
29343571
3.

Multiplex single-cell visualization of nucleic acids and protein during HIV infection.

Puray-Chavez M, Tedbury PR, Huber AD, Ukah OB, Yapo V, Liu D, Ji J, Wolf JJ, Engelman AN, Sarafianos SG.

Nat Commun. 2017 Dec 1;8(1):1882. doi: 10.1038/s41467-017-01693-z.

4.

3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H.

Huber AD, Michailidis E, Tang J, Puray-Chavez MN, Boftsi M, Wolf JJ, Boschert KN, Sheridan MA, Leslie MD, Kirby KA, Singh K, Mitsuya H, Parniak MA, Wang Z, Sarafianos SG.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00245-17. doi: 10.1128/AAC.00245-17. Print 2017 Jun.

5.

A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates.

Swaminathan G, Thoryk EA, Cox KS, Smith JS, Wolf JJ, Gindy ME, Casimiro DR, Bett AJ.

Sci Rep. 2016 Oct 5;6:34215. doi: 10.1038/srep34215.

6.

An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors.

Poulet FM, Wolf JJ, Herzyk DJ, DeGeorge JJ.

Birth Defects Res B Dev Reprod Toxicol. 2016 Apr;107(2):108-19. doi: 10.1002/bdrb.21176. Epub 2016 Apr 7. Review.

PMID:
27062127
7.

Reliable quantification of mRNA in archived formalin-fixed tissue with or without paraffin embedding.

Wang Z, Lebron JA, Wolf JJ.

J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:103-9. doi: 10.1016/j.vascn.2014.09.007. Epub 2014 Sep 30.

PMID:
25280797
8.

Synthetic RNA switches as a tool for temporal and spatial control over gene expression.

Chang AL, Wolf JJ, Smolke CD.

Curr Opin Biotechnol. 2012 Oct;23(5):679-88. doi: 10.1016/j.copbio.2012.01.005. Epub 2012 Feb 3. Review.

9.

Psychosomatic symptoms among hospital physicians during the Gaza War: a repeated cross-sectional study.

Ben-Ezra M, Palgi Y, Wolf JJ, Shrira A.

Isr J Psychiatry Relat Sci. 2011;48(3):170-4.

10.

Correlations between psychosocial factors and psychological trauma symptoms among rescue personnel.

Soffer Y, Wolf JJ, Ben-Ezra M.

Prehosp Disaster Med. 2011 Jun;26(3):166-9. doi: 10.1017/S1049023X11006224.

PMID:
22107766
11.

Psychiatric symptoms and psychosocial functioning among hospital personnel during the Gaza War: a repeated cross-sectional study.

Ben-Ezra M, Palgi Y, Wolf JJ, Shrira A.

Psychiatry Res. 2011 Oct 30;189(3):392-5. doi: 10.1016/j.psychres.2011.02.004. Epub 2011 Feb 26.

PMID:
21354628
12.

Comorbidity of posttraumatic stress symptoms and depressive symptoms among gastric cancer patients.

Palgi Y, Shrira A, Haber Y, Wolf JJ, Goldray O, Shacham-Shmueli E, Ben-Ezra M.

Eur J Oncol Nurs. 2011 Dec;15(5):454-8. doi: 10.1016/j.ejon.2010.11.011. Epub 2011 Jan 8.

PMID:
21220210
13.

A multi-species assay for siRNA-mediated mRNA knockdown analysis without the need for RNA purification.

Wang Z, Pacchione SJ, Niu Z, Troilo PJ, Griffiths TG, Striano KL, Lebron JA, Wolf JJ.

J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):174-9. doi: 10.1016/j.vascn.2010.09.006. Epub 2010 Sep 25.

PMID:
20884365
14.

Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats.

Wise LD, Pauley CJ, Michael B, Wolf JJ.

Birth Defects Res B Dev Reprod Toxicol. 2010 Oct;89(5):376-81. doi: 10.1002/bdrb.20259.

PMID:
20836123
15.

Feed-forward regulation of a cell fate determinant by an RNA-binding protein generates asymmetry in yeast.

Wolf JJ, Dowell RD, Mahony S, Rabani M, Gifford DK, Fink GR.

Genetics. 2010 Jun;185(2):513-22. doi: 10.1534/genetics.110.113944. Epub 2010 Apr 9.

16.

Nonclinical safety assessment of vaccines and adjuvants.

Wolf JJ, Kaplanski CV, Lebron JA.

Methods Mol Biol. 2010;626:29-40. doi: 10.1007/978-1-60761-585-9_3. Review.

PMID:
20099119
17.

Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats.

Wise LD, Wolf JJ, Kaplanski CV, Pauley CJ, Ledwith BJ.

Birth Defects Res B Dev Reprod Toxicol. 2008 Dec;83(6):561-72. doi: 10.1002/bdrb.20174.

PMID:
19025783
18.

Quantifying the titer and quality of adenovirus stocks.

Wang F, Mathis BC, Montalvo A, Wolf JJ, Lewis JA.

Methods Mol Biol. 2008;434:25-36. doi: 10.1007/978-1-60327-248-3_3.

PMID:
18470637
19.

Application of PCR technology in vaccine product development.

Wolf JJ, Wang L, Wang F.

Expert Rev Vaccines. 2007 Aug;6(4):547-58. Review.

PMID:
17669009
20.

Production and formulation of adenovirus vectors.

Altaras NE, Aunins JG, Evans RK, Kamen A, Konz JO, Wolf JJ.

Adv Biochem Eng Biotechnol. 2005;99:193-260. Review.

PMID:
16568893
21.

Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line.

Ledwith BJ, Lanning CL, Gumprecht LA, Anderson CA, Coleman JB, Gatto NT, Balasubramanian G, Farris GM, Kemp RK, Harper LB, Barnum AB, Pacchione SJ, Mauer KL, Troilo PF, Brown ER, Wolf JJ, Lebronl JA, Lewis JA, Nichols WW.

Dev Biol (Basel). 2006;123:251-63; discussion 265-6.

PMID:
16566451
22.

Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines.

Lebron JA, Troilol PJ, Pacchione S, Griffiths TG, Harper LB, Mixson LA, Jackson BE, Michna L, Barnum AB, Denisova L, Johnson CN, Maurer KL, Morgan-Hoffman S, Niu Z, Roden DF, Wang Z, Wolf JJ, Hamilton TR, Laux KM, Soper KA, Ledwith BJ.

Dev Biol (Basel). 2006;123:35-44; discussion 55-73.

PMID:
16566435
23.

Ensuring the quality, potency and safety of vaccines during preclinical development.

Lebron JA, Wolf JJ, Kaplanski CV, Ledwith BJ.

Expert Rev Vaccines. 2005 Dec;4(6):855-66. Review.

PMID:
16372881
24.

Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.

Wang F, Puddy AC, Mathis BC, Montalvo AG, Louis AA, McMackin JL, Xu J, Zhang Y, Tan CY, Schofield TL, Wolf JJ, Lewis JA.

Vaccine. 2005 Aug 22;23(36):4500-8.

PMID:
16002190
25.

A cytosine analog that confers enhanced potency to antisense oligonucleotides.

Flanagan WM, Wolf JJ, Olson P, Grant D, Lin KY, Wagner RW, Matteucci MD.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3513-8.

26.

Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons.

Toledo-Aral JJ, Moss BL, He ZJ, Koszowski AG, Whisenand T, Levinson SR, Wolf JJ, Silos-Santiago I, Halegoua S, Mandel G.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1527-32.

27.

Effects of antibodies against N-cadherin and N-CAM on the cranial neural crest and neural tube.

Bronner-Fraser M, Wolf JJ, Murray BA.

Dev Biol. 1992 Oct;153(2):291-301.

PMID:
1397686
28.

A new method for the scientific layout of workspaces.

Siegel AI, Wolf JJ, Pilitsis J.

Appl Ergon. 1982 Jun;13(2):87-90.

PMID:
15676429

Supplemental Content

Support Center